JPRN-jRCT2031230312招募中3 期
SJP-0135 Phase 3 -A Multicenter, Randomized, Double-Masked, Active-Controlled, Parallel-Group Study in Patients with Primary Open Angle Glaucoma or Ocular Hypertension
Omatsu Kazunori0 个研究点目标入组 140 人开始时间: 2023年9月14日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 招募中
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Aged 18 years or older at the time of Informed Consent (any gender)
- •-Have been diagnosed with primary open angle glaucoma or ocular hypertension
- •-Meet the other protocol-specified inclusion criteria
排除标准
- •-Have a history of, or scheduled ocular surgery/laser therapy during the study
- •-Unable to discontinue wearing contact lens during the study
- •-Have active ocular disease other than primary open angle glaucoma or ocular hypertension
- •-Have severe visual field disorders
- •-Have abnormalities that interfere with measurement of intraocular pressure
- •-Have severe systemic illness
- •-Have a history of hypersensitivity or serious adverse reaction to any of the drugs used in the study
- •-Pregnant, lactating, or potentially pregnant
- •-Have judged that it is inappropriate to participate in this study by investigator
- •-Meet the other protocol-specified exclusion criteria
研究者
相似试验
进行中（未招募）
3 期
Placebo Controlled, Parallel-Group Study of SJP-0132 in Patients with Dry Eye DiseaseDry Eye DiseaseJPRN-jRCT2031220497Omatsu Kazunori498
已完成
3 期
A Study to Determine the Effect of Aztreonam-Avibactam Versus Meropenem for the Treatment of Serious Infections Due to Gram Negative Bacteria.CTRI/2018/09/015762Pfizer Limited27
尚未招募
不适用
REVISIT-A048 Other specified bacterial intestinal infections-J168 Pneumonia due to other specified infectious organismsOther specified bacterial intestinal infectionsPneumonia due to other specified infectious organismsA048J168PER-014-18Pfizer Inc.,
进行中（未招募）
1 期
A study to determine whether the addition of Dostarlimab (TSR-042) delays recurrence of advanced endometrial cancerRecurrent or primary advanced (Stage III or IV) endometrial cancerMedDRA version: 21.0Level: PTClassification code: 10014741Term: Endometrial cancer stage IV Class: 100000004864MedDRA version: 21.0Level: PTClassification code: 10014740Term: Endometrial cancer stage III Class: 100000004864CTIS2023-506551-23-00Tesaro Inc.785
已完成
不适用
A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTER STUDY TO EVALUATE THE SAFETY AND EFFICACY OF INTRAVENOUS ICLAPRIM VERSUS VANCOMYCIN IN THE TREATMENT OF ACUTE BACTERIAL SKIN AND SKIN STRUCTURE INFECTIONS SUSPECTED OR CONFIRMED TO BE DUE TO GRAM-POSITIVE PATHOGENS. REVIVE-1-L00 Staphylococcal scalded skin syndromeL00Staphylococcal scalded skin syndromePER-013-16Motif BioSciences Inc.,9